Mint Explainer: Can India become a global hub for biologic drugs? Here’s the plan
India is betting ₹13,000 crore to move beyond generics into high-value biologics and advanced chemicals. Here’s how it plans to build talent, ensure safety and tap a $300 billion global opportunity.
India is betting ₹13,000 crore to move beyond generics into high-value biologics and advanced chemicals. Here’s how it plans to build talent, ensure safety and tap a $300 billion global opportunity.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
